Correlation Between Oramed Pharmaceuticals and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Oramed Pharmaceuticals and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oramed Pharmaceuticals and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oramed Pharmaceuticals and Capricor Therapeutics, you can compare the effects of market volatilities on Oramed Pharmaceuticals and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oramed Pharmaceuticals with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oramed Pharmaceuticals and Capricor Therapeutics.
Diversification Opportunities for Oramed Pharmaceuticals and Capricor Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Oramed and Capricor is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Oramed Pharmaceuticals and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Oramed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oramed Pharmaceuticals are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Oramed Pharmaceuticals i.e., Oramed Pharmaceuticals and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Oramed Pharmaceuticals and Capricor Therapeutics
Given the investment horizon of 90 days Oramed Pharmaceuticals is expected to under-perform the Capricor Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Oramed Pharmaceuticals is 1.08 times less risky than Capricor Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Capricor Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 407.00 in Capricor Therapeutics on August 29, 2024 and sell it today you would earn a total of 1,497 from holding Capricor Therapeutics or generate 367.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oramed Pharmaceuticals vs. Capricor Therapeutics
Performance |
| Timeline |
| Oramed Pharmaceuticals |
| Capricor Therapeutics |
Oramed Pharmaceuticals and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oramed Pharmaceuticals and Capricor Therapeutics
The main advantage of trading using opposite Oramed Pharmaceuticals and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oramed Pharmaceuticals position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| Oramed Pharmaceuticals vs. Protalix Biotherapeutics | Oramed Pharmaceuticals vs. Corvus Pharmaceuticals | Oramed Pharmaceuticals vs. Aldeyra | Oramed Pharmaceuticals vs. Checkpoint Therapeutics |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |